Generic Liletta Availability
Last updated on Oct 6, 2021.
LILETTA (levonorgestrel - intrauterine device;intrauterine)
Approval date: February 26, 2015
Has a generic version of Liletta been approved?
No. There is currently no therapeutically equivalent version of Liletta available in the United States.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Liletta. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Intrauterine systems, IUD insertion devices, and related methods and kits therefor
Issued: July 24, 2018
Intrauterine systems and components thereof. The systems include an intrauterine device (IUD), an insertion device or applicator for inserting the IUD into the cervix of a female patient. The insertion device includes an elongated sheath; an elongated inner member positioned within a lumen of the elongated sheath; a handle with one or more elongated guides; and a moveable sheath slider. Additionally, methods related to the insertion procedure, and methods of manufacture for the insertion device.
Patent expiration dates:
- March 22, 2034✓✓
- March 22, 2034
Patent expiration dates:
- October 24, 2033✓
- October 24, 2033
More about Liletta (levonorgestrel)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 587 Reviews
- Drug class: contraceptives
- FDA Approval History
Related treatment guides
|Drug Patent||A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation.|
|Drug Exclusivity||Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.